Clinical Trial Update: A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer [Phase 3]

View source ↗

Summary

This document reports on an ongoing Phase 3, single-arm study evaluating UGN-104 for low-grade upper urinary tract urothelial carcinoma, with recruitment curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Urinary Tract Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• UGN-104

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | Phase 3 | Status: RECRUITING